Research and Development

Showing 15 posts of 9596 posts found.

Chiltern welcomes Krista Stephenson to the global resourcing solutions team

March 2, 2012 Research and Development

 London, UK, February 28, 2012: Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Krista Stephenson has …

Good Pharmacovigilance Practice modules released by European Medicine Agency

March 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation.  …
Lilly scientists

Academic alliances to speed Lilly’s R&D

March 1, 2012 Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly

Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …

AstraZeneca announces several non-executive moves

March 1, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, appointments

AstraZeneca has announced that Leif Johansson is set to be elected as a non-executive director in April, with the intention …

Novartis appoints Brian McNamara to division head of OTC business

March 1, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC

Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …
Rare Disease Day

‘Rare Disease Day’ highlights need for research

February 29, 2012 Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire

 Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …

A wake-up call for big pharma

February 29, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma

The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …
Abbott image

Abbott buys into Galapagos’ RA candidate

February 29, 2012 Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …
Shire image

Shire signs antibody research deal with arGEN-X

February 29, 2012 Research and Development Shire, arGEN-X, monoclonal antibodies

Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …

LEO Pharma appoints new executive vice president

February 29, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain

From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …

NHS must adopt new technologies faster, says minister

February 28, 2012 Research and Development ABPI, NHS, Whitehead, Willetts, innovation

The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …

ICON acquires market access consultancy

February 28, 2012 Research and Development CRO, ICON, pharma market access, pricing and reimbursement

ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …

EMA accepts Genzyme MS drug for review

February 24, 2012 Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide

The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide.  Genzyme, which is wholly owned by …
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …
The Gateway to Local Adoption Series

Latest content